Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CD40 | P25942 | 1/20 | 0.36 |
| ▸ | CD40LG | P29965 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.31 |
| ▸ | ATIC | P31939 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | P2RX5 | Q93086 | 1/20 | 0.30 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.30 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14004258 | 0.91 | CD40 (0.37) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14029605 | 0.90 | ENPP2 (0.37) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004257 | 0.84 | CD40 (0.37) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004267 | 0.84 | CD40 (0.35) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14625588 | 0.83 | ENPP2 (0.38) | MAPTALDH1A1CD40CD40LGENPP2 | |
| SCHEMBL14004569 | 0.83 | CD40 (0.41) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004288 | 0.81 | CD40 (0.40) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004289 | 0.81 | CD40 (0.40) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004349 | 0.81 | CD40 (0.38) | KMT2AMAPTMEN1ALDH1A1PKM | |
| SCHEMBL14004355 | 0.81 | CD40 (0.38) | KMT2AMAPTMEN1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080289124-A1 | Reactive Azo Dyes, Methods for the Production Thereof and Their Use | IK, CYP1A1, ALKBH1 | KMT2A 801/4885MAPT 3286/4885MEN1 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.